Mehmet Emrah Bayam
Research Subjects
Research Interests
Mehmet Emrah Bayam has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Berkay Demir
Department of Gastrointestinal Surgery, Ankara Bilkent City Hospital, Ankara, Türkiye
1 shared publication - Funda Taşlı
Department of Pathology, İzmir City Hospital, İzmir, Türkiye
1 shared publication Gökhan Gökten
Department of General Surgery, Çanakkale Mehmet Akif Ersoy State Hospital, Çanakkale, Türkiye
1 shared publicationHakan Postaci
Pathology, Izmir Bozyaka Teaching and Research Hospital, Izmir, Turkey
1 shared publication- Mehmet Ali Karacaer
Mehmet Akif Ersoy Devlet Hastanesi
1 shared publication - Mehmet Fatih Erol
Department of General Surgery, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
1 shared publication
Latest Publications
- 9 February 2026
- Published by Reial Acadèmia de Medicina de les Illes Balears in Academic Journal of Health Sciences
- Vol. 41 (1) , 56-63
TIRADS classification and histopathological correlation in thyroidectomy cases: how accurate is the risk stratification?
Objectives: Thyroid nodules, although frequently benign, carry a malignancy risk in approximately 8–16% of cases. The use of structured classification systems such as TIRADS and cytological evaluation via fine needle aspiration biopsy (FNAB) help guide clinical decision-making and avoid unnecessary surgery. This study aimed to evaluate the sensitivity, specificity, and diagnostic accuracy of TIRADS classification and FNAB in predicting malignancy in thyroid nodules and to assess their correlation with final histopathological outcomes after thyroidectomy. Methods: A retrospective analysis was conducted on 489 patients who underwent thyroidectomy between January 2016 and July 2020, in accordance with ATA guidelines. Data collected included demographic features, comorbidities, ultrasound-based TIRADS classifications, FNAB results (Bethesda classification), preoperative and postoperative biochemical parameters, and final histopathological diagnoses. Results: Malignancy was detected in 9.48% of cases. The mean age of malignant cases was 48.8 years. FNAB showed a sensitivity of 50%, specificity of 98%, negative predictive value of 87.4%, and positive predictive value of 88.5%. Among nodules categorized as “suspicious for malignancy” by FNAB, 51.4% were confirmed as malignant on final pathology. The malignancy rates according to TIRADS scores 1 to 5 were 7.1%, 20.3%, 27.1%, 37.1%, and 57.1%, respectively. When only malignant and suspicious-for-malignancy FNAB results were considered positive, the malignancy risk was 33.6% for TIRADS 4 and 83.3% for TIRADS 5 nodules. Conclusion: This study revealed notable malignancy rates even in TIRADS 1 and 2 nodules, which are generally considered benign in current guidelines. TIRADS categories 4 and 5 showed statistically significant correlations with malignancy, reinforcing their utility in preoperative risk stratification.
- 9 February 2026
- Published by Reial Acadèmia de Medicina de les Illes Balears in Academic Journal of Health Sciences
- Vol. 41 (1) , 56-63
TIRADS classification and histopathological correlation in thyroidectomy cases: how accurate is the risk stratification?
Objectives: Thyroid nodules, although frequently benign, carry a malignancy risk in approximately 8–16% of cases. The use of structured classification systems such as TIRADS and cytological evaluation via fine needle aspiration biopsy (FNAB) help guide clinical decision-making and avoid unnecessary surgery. This study aimed to evaluate the sensitivity, specificity, and diagnostic accuracy of TIRADS classification and FNAB in predicting malignancy in thyroid nodules and to assess their correlation with final histopathological outcomes after thyroidectomy. Methods: A retrospective analysis was conducted on 489 patients who underwent thyroidectomy between January 2016 and July 2020, in accordance with ATA guidelines. Data collected included demographic features, comorbidities, ultrasound-based TIRADS classifications, FNAB results (Bethesda classification), preoperative and postoperative biochemical parameters, and final histopathological diagnoses. Results: Malignancy was detected in 9.48% of cases. The mean age of malignant cases was 48.8 years. FNAB showed a sensitivity of 50%, specificity of 98%, negative predictive value of 87.4%, and positive predictive value of 88.5%. Among nodules categorized as “suspicious for malignancy” by FNAB, 51.4% were confirmed as malignant on final pathology. The malignancy rates according to TIRADS scores 1 to 5 were 7.1%, 20.3%, 27.1%, 37.1%, and 57.1%, respectively. When only malignant and suspicious-for-malignancy FNAB results were considered positive, the malignancy risk was 33.6% for TIRADS 4 and 83.3% for TIRADS 5 nodules. Conclusion: This study revealed notable malignancy rates even in TIRADS 1 and 2 nodules, which are generally considered benign in current guidelines. TIRADS categories 4 and 5 showed statistically significant correlations with malignancy, reinforcing their utility in preoperative risk stratification.
- Open Access
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 223-230
Comparison of neutrophil lymphocyte ratio and platelet lymphocyte ratio with Ranson criteria in acute biliary pancreatitis
Aim: To evaluate the diagnostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting the severity of acute biliary pancreatitis, in comparison with the Ranson scoring system. Methods: A total of 353 patients diagnosed with acute biliary pancreatitis between January 2019 and December 2023 were retrospectively analyzed. Demographic data, laboratory findings, NLR, PLR, and Ranson scores were recorded. Patients were grouped as mild and severe according to clinical severity. The diagnostic performances of NLR, PLR, and Ranson score were assessed using receiver operating characteristic (ROC) curve analysis. Results: NLR, PLR, and Ranson scores were significantly higher in the severe pancreatitis group compared to the mild group (p<0.001 for all). ROC analysis revealed that Ranson score had the highest area under the curve (AUC = 0.85), followed by NLR (AUC = 0.82) and PLR (AUC = 0.75). Sensitivity and specificity values were acceptable for all three parameters in distinguishing severe disease. Conclusion: NLR and PLR are simple, cost-effective, and accessible inflammatory markers that may assist in predicting disease severity in acute biliary pancreatitis. Their diagnostic power is comparable to the Ranson scoring system and may support early risk stratification in clinical practice.
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 223-230
Open AccessComparison of neutrophil lymphocyte ratio and platelet lymphocyte ratio with Ranson criteria in acute biliary pancreatitis
Aim: To evaluate the diagnostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting the severity of acute biliary pancreatitis, in comparison with the Ranson scoring system. Methods: A total of 353 patients diagnosed with acute biliary pancreatitis between January 2019 and December 2023 were retrospectively analyzed. Demographic data, laboratory findings, NLR, PLR, and Ranson scores were recorded. Patients were grouped as mild and severe according to clinical severity. The diagnostic performances of NLR, PLR, and Ranson score were assessed using receiver operating characteristic (ROC) curve analysis. Results: NLR, PLR, and Ranson scores were significantly higher in the severe pancreatitis group compared to the mild group (p<0.001 for all). ROC analysis revealed that Ranson score had the highest area under the curve (AUC = 0.85), followed by NLR (AUC = 0.82) and PLR (AUC = 0.75). Sensitivity and specificity values were acceptable for all three parameters in distinguishing severe disease. Conclusion: NLR and PLR are simple, cost-effective, and accessible inflammatory markers that may assist in predicting disease severity in acute biliary pancreatitis. Their diagnostic power is comparable to the Ranson scoring system and may support early risk stratification in clinical practice.
- Open Access
- 1 March 2010
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 19 (3) , 232-234
A Rare Cause of Small Bowel Transection: Metastatic Lung Cancer
Objective: To present a case of small bowel perforation due to metastatic lung cancer. Case Presentation and Intervention: A 78-year-old male patient, who had been diagnosed with lung cancer 3 months earlier, presented to our clinic with acute abdominal pain. He underwent emergency laparotomy. At surgery, there was a circumferential lesion encompassing the ileum with complete transection. There was no obvious macroscopic appearance of metastatic disease. The involved bowel segment was resected and an ileostomy was performed. Postoperative pathologic analysis confirmed metastatic squamous cell carcinoma metastasis to the ileum, arising from the patient’s lung cancer. Conclusion: This case report showed that small bowel metastases should always be considered in the differential diagnosis of lung cancer patients presenting with acute abdominal pain.
- 1 March 2010
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 19 (3) , 232-234
Open AccessA Rare Cause of Small Bowel Transection: Metastatic Lung Cancer
Objective: To present a case of small bowel perforation due to metastatic lung cancer. Case Presentation and Intervention: A 78-year-old male patient, who had been diagnosed with lung cancer 3 months earlier, presented to our clinic with acute abdominal pain. He underwent emergency laparotomy. At surgery, there was a circumferential lesion encompassing the ileum with complete transection. There was no obvious macroscopic appearance of metastatic disease. The involved bowel segment was resected and an ileostomy was performed. Postoperative pathologic analysis confirmed metastatic squamous cell carcinoma metastasis to the ileum, arising from the patient’s lung cancer. Conclusion: This case report showed that small bowel metastases should always be considered in the differential diagnosis of lung cancer patients presenting with acute abdominal pain.